David Jin - Net Worth and Insider Trading
David Jin Net Worth
The estimated net worth of David Jin is at least $165,534 dollars as of 2024-11-05. David Jin is the CFO of Fortress Biotech Inc and owns about 93,522 shares of Fortress Biotech Inc (FBIO) stock worth over $165,534. Details can be seen in David Jin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Jin has not made any transactions after 2022-11-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Jin
David Jin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Jin owns 2 companies in total, including Avenue Therapeutics Inc (ATXI) , and Fortress Biotech Inc (FBIO) .
Click here to see the complete history of David Jin’s form 4 insider trades.
Insider Ownership Summary of David Jin
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATXI | Avenue Therapeutics Inc | 2022-05-11 | Int. PEO & Int. PFO & and COO |
| FBIO | Fortress Biotech Inc | 2022-11-30 | Chief Financial Officer |
David Jin Latest Holdings Summary
David Jin currently owns a total of 1 stock. David Jin owns 93,522 shares of Fortress Biotech Inc (FBIO) as of November 30, 2022, with a value of $165,534.
Latest Holdings of David Jin
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| FBIO | Fortress Biotech Inc | 2022-11-30 | 93,522 | 1.77 | 165,534 |
Holding Weightings of David Jin
David Jin Form 4 Trading Tracker
According to the SEC Form 4 filings, David Jin has made a total of 1 transactions in Fortress Biotech Inc (FBIO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Fortress Biotech Inc is the acquisition of 333 shares on November 30, 2022, which cost David Jin around $2,800.
Insider Trading History of David Jin
- 1
David Jin Trading Performance
GuruFocus tracks the stock performance after each of David Jin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David Jin is 13.41%. GuruFocus also compares David Jin's trading performance to market benchmark return within the same time period. The performance of stocks bought by David Jin within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David Jin's insider trading performs compared to the benchmark.
Performance of David Jin
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.95 | | | | | |
| Relative Return to S&P 500(%) | 4.95 | | | | | |
David Jin Ownership Network
Ownership Network List of David Jin
Ownership Network Relation of David Jin
David Jin Owned Company Details
What does Avenue Therapeutics Inc do?
Who are the key executives at Avenue Therapeutics Inc?
David Jin is the Int. PEO & Int. PFO & and COO of Avenue Therapeutics Inc. Other key executives at Avenue Therapeutics Inc include 10 percent owner Fortress Biotech, Inc. , 10 percent owner Invagen Pharmaceuticals, Inc. , and Chief Executive Officer Alexandra Maclean .
Avenue Therapeutics Inc (ATXI) Insider Trades Summary
Over the past 18 months, David Jin made no insider transaction in Avenue Therapeutics Inc (ATXI). Other recent insider transactions involving Avenue Therapeutics Inc (ATXI) include a net sale of 617,000 shares made by , a net purchase of 418,410 shares made by Fortress Biotech, Inc. , and a net purchase of 348,675 shares made by Rosenwald Lindsay A Md .
In summary, during the past 3 months, insiders sold 0 shares of Avenue Therapeutics Inc (ATXI) in total and bought 500 shares, with a net purchase of 500 shares. During the past 18 months, 8,227 shares of Avenue Therapeutics Inc (ATXI) were sold and 10,728 shares were bought by its insiders, resulting in a net purchase of 2,501 shares.
Avenue Therapeutics Inc (ATXI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Avenue Therapeutics Inc Insider Transactions
David Jin Mailing Address
Above is the net worth, insider trading, and ownership report for David Jin. You might contact David Jin via mailing address: C/o Avenue Therapeutics, Inc., 1140 Avenue Of The Americas, Floor 9, New York Ny 10036.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
